Clinical Trials in Denver

Showing 101-120 of 15,604 trials

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07335497

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.

Locally Advanced / Metastatic Solid Tumors

Crescent Biopharma, Inc.290 participantsStarted Feb 2026

Denver, Colorado, United States • Orlando, Florida, United States • Sarasota, Florida, United States +7 more locations

Active Not RecruitingPhase 2< 1 mile

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

NCT04597359

This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.

Prostate Carcinoma

ECOG-ACRIN Cancer Research Group360 participantsStarted Oct 2021

Fairbanks, Alaska, United States • Phoenix, Arizona, United States • Fayetteville, Arkansas, United States +350 more locations

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Find Trials by Condition in Denver

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

ALIGN for Older Adults With Cancer in SNFs

Gastroschisis Outcomes of Delivery (GOOD) Study

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Confirm Rx Insertable Cardiac Monitor SMART Registry

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

RevCore for In Stent Thrombosis

Study of SGN1 in Patients With Advanced Solid Tumor

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma